Lead Sponsor: Aerie Pharmaceuticals

Intervention / Treatment: DRUG: AR-15512 Ophthalmic Solution, DRUG: AR-15512 Ophthalmic Solution Vehicle

Lead Sponsor: Surface Ophthalmics, Inc.

Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion

Lead Sponsor: Tarsus Pharmaceuticals, Inc.

Intervention / Treatment: DRUG: TP-03 Vehicle, DRUG: TP-03, 0.25%